Larvol Delta - Adhera-Therapeutics-Receives-Notice-of-Allowance-for-New-Canadian-Patent-Covering-MLR1019-for-Dyskinesia-and-Related-Disorders

armesocarb (MLR-1019) - Melior, Adhera Therap

https://www.globenewswire.com/news-release/2021/11/22/2339159/0/en/Adhera-Therapeutics-Receives-Notice-of-Allowance-for-New-Canadian-Patent-Covering-MLR-1019-for-Dyskinesia-and-Related-Disorders.html

Nov 22, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next